Dr. Jörg Lippert
Bayer AG, Berlin
A physicist with PhD in neurobiology, Jörg heads the Pharmacometrics department at Bayer Pharmaceuticals responsible for all model-based analyses in drug development. Activities cover data-based approaches as well as knowledge-driven, mechanistic, systems modeling. Previously Jörg has worked in data mining and has established and led a contract research organization for Systems Biology & Pharmacology. Earlier this year, Jörg and his team have spun-off their formerly commercial proprietary modeling & simulation software platform “Open System Pharmacology” (consisting of PK-Sim® and MoBi®).
At Future Medicine 2017 he will talk about "Beyond Randomized Controlled Trials - New Source of Clinical Insight"